Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis.
about
Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapyPhosphatase and Tensin Homologue: Novel Regulation by Developmental SignalingMolecularly targeted therapies for malignant glioma: rationale for combinatorial strategies.Notch signaling in glioblastoma: a developmental drug target?Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors.Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3Cytotoxic autophagy in cancer therapy.Advances in strategies to improve drug delivery to brain tumors.Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies.Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in (12) V-Ha-Ras transgenic mouse glioma model.Molecular Targets and Treatment of Meningioma.Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin.Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.Hedgehog Signaling Components Are Expressed in Choroidal Neovascularization in Laser-induced Retinal LesionMolecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.Small molecule and monoclonal antibody therapies in neurooncology.Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle.Chemotherapy for malignant glioma.Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future.Molecular biology of human gliomas.The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas.Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment.Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasionEmerging monoclonal antibody therapies for malignant gliomas.Inhibiting kinases in malignant gliomas.Molecularly targeted therapies for malignant gliomas: advances and challenges.Inhibition of angiogenesis and invasion in malignant gliomas.Combination therapy for malignant glioma based on PTEN status.New strategies to deliver anticancer drugs to brain tumors.PI3Kinase signaling in glioblastoma.Malignant glioma drug discovery - targeting protein kinases.Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.Novel chemotherapeutics and other therapies for treating high-grade glioma.Akt2 and Akt3 play a pivotal role in malignant gliomas.Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo.Gene therapy for malignant glioma.Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue.
P2860
Q24655510-410668B3-A635-4B35-BD29-5A56EBF4338AQ26784590-91B837E7-7621-475D-A142-B01DC255604DQ33644407-7FE96043-945A-47FD-9563-F9A6FE1B8B04Q33747041-BBFCBF0B-7B0B-4B57-83AB-02A3AFDE60DFQ33760569-C4A6CF0D-422C-406A-8561-540B9E54F639Q33780701-8B2324AA-C4AE-4F35-AD3D-A8F529EF0AC2Q33907663-322EB25B-B498-4818-BBCF-AC0ED506B0D2Q34000631-960BE3A2-8E41-48FC-87D9-3B4F776999ACQ34132781-1DA1005C-D3BC-49E8-9630-67701B899105Q34191508-556B2F9E-88E8-4B1A-BA11-B318EE413FC5Q34568628-DA7167E3-D57C-4DA6-AE8E-0007644C5643Q34631513-44CD31E7-351B-4A50-B645-14F6F4AAD892Q34886884-D9172FBA-89F7-4551-A9FB-32E733258BFCQ35234447-2AECADF3-60F4-4A2F-AA55-66168773763DQ35440540-B5F46770-551F-4E8A-9EE7-CEBFACF591BBQ35800467-728CDA3F-52F2-4380-99DB-F10BF4DC921BQ36033617-3E186B5E-6370-4A56-AD5C-B5F004C9C3E5Q36066191-A01E103E-29E6-41B8-8469-D0B7C8C62761Q36108621-84101F54-3759-46E8-8EB5-E76CEDDB27D3Q36118431-3B92F415-9BDC-4571-B0BC-D7BBBFE7AC43Q36307802-2BD96FE1-539D-4137-8066-29DBFF6ED4F4Q36429731-EF8DECE5-3C11-4518-A21D-CBF0AA109C0BQ36478640-1E287B3A-A839-4A6C-913E-6C1ABC693710Q36485266-CC513948-CCB1-4E12-9971-A649B4EB3769Q36499234-1EC8B343-AEBB-4317-A1E0-90371DDE91CEQ36677119-34D17A3F-0997-489E-A310-2AE932DED6D5Q36764016-EDC1E29A-BC23-4778-8701-A17D61278B64Q36764876-78771F32-4C04-4BC4-84FE-5C4E5C4F5B1EQ36817109-A3F3D037-8356-4A80-ACA0-F76C74796260Q37004664-D0FAEDD5-C826-4633-9D17-9680B9071A15Q37316986-69897295-95D1-44AF-B421-49DFB5566CD8Q37364700-CE899086-B50C-4485-A967-7960CA043236Q37808385-CDF66DCC-BEF0-48D1-BDD6-BD83A89D7C03Q38089834-7CD6EEE0-193A-4D1E-BBDE-90C36F0E7CE4Q38401892-80E323A3-AEDF-457D-B450-2CFC0941282DQ38569802-71FB30BD-3F7F-48ED-8002-3AD11DDE598CQ42426022-01EAD852-3B81-4C32-8A42-377A5771ABC3Q45855175-2A21C245-55C4-40AB-99E4-F94D9780C897Q45857497-05A69435-E4F6-4934-ACC9-022D1F7DF645Q46427095-E2EF6849-3AB6-4392-91C3-10DBDD9832C5
P2860
Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Molecular neuro-oncology and d ...... OR, SHH/PTCH and angiogenesis.
@ast
Molecular neuro-oncology and d ...... OR, SHH/PTCH and angiogenesis.
@en
type
label
Molecular neuro-oncology and d ...... OR, SHH/PTCH and angiogenesis.
@ast
Molecular neuro-oncology and d ...... OR, SHH/PTCH and angiogenesis.
@en
prefLabel
Molecular neuro-oncology and d ...... OR, SHH/PTCH and angiogenesis.
@ast
Molecular neuro-oncology and d ...... OR, SHH/PTCH and angiogenesis.
@en
P2860
P356
P1476
Molecular neuro-oncology and d ...... OR, SHH/PTCH and angiogenesis.
@en
P2093
Herbert B Newton
P2860
P304
P356
10.1586/14737140.4.1.105
P577
2004-02-01T00:00:00Z